Aardvark Therapeutics (AARD) Balance Sheet Analysis 2022-2026

Metric	2024	2025	LTM
Total Cash And Short-Term Investments	$73.663M	$110.027M	$91.2M
Net Receivables	-	-	-
Inventory	-	-	-
Prepaid Expenses And Other Current Assets	$314K	-	-
Other Current Assets	$0.16M	$1.859M	$2.38M
Total Current Assets	$74.137M	$111.886M	$93.58M
Property, Plant And Equipment	$735K	$355K	$269K
Goodwill And Intangible Assets	-	-	-
Long-Term Investments	-	-	-
Deferred Tax Assets	-	-	-
Other Noncurrent Assets	$2.635M	$4.94M	$4.741M
Total Noncurrent Assets	$3.37M	$5.295M	$5.01M
Other Assets	-	-	-
Total Assets	$77.507M	$117.181M	$98.59M

Metric	2024	2025	LTM
Total Payables	$2.298M	$2.072M	$4.493M
Accrued Expenses	$1.395M	-	-
Short-Term Debt	-	$441K	$336K
Current Portion Of Lease Obligations	$338K	-	-
Income Taxes Payable	-	-	-
Current Deferred Revenue	-	-	-
Other Current Liabilities	$0.896M	$8.035M	$6.775M
Total Current Liabilities	$4.927M	$10.548M	$11.604M
Long-Term Debt	$-441K	-	-
Capital Lease Obligations	$779K	-	-
Noncurrent Deferred Revenue	-	-	-
Noncurrent Deferred Tax Liabilities	-	-	-
Other Noncurrent Liabilities	$126.782M	-	-
Total Noncurrent Liabilities	$127.223M	-	-
Other Liabilities	-	-	-
Total Liabilities	$132.15M	$10.548M	$11.604M

Metric	2024	2025	LTM
Treasury Stock	-	-	-
Preferred Stock	-	-	-
Common Stock	-	-	-
Retained Earnings	$-58.327M	$-115.918M	$-137.506M
Additional Paid-In Capital	$3.684M	$222.47M	$224.478M
Accumulated Other Comprehensive Income	-	$81K	$14K
Other Stockholders' Equity	-	-	-
Total Common Stockholders' Equity	$-54.643M	$106.633M	$86.986M
Minority Interest	-	-	-
Total Equity	$-54.643M	$106.633M	$86.986M
Total Liabilities And Equity	$77.507M	$117.181M	$98.59M

Metric	2024	2025	LTM
Total Investments	$12.022M	$62.976M	$28.764M
Total Debt	$779K	$441K	$336K
Net Debt	$-60.862M	$-46.61M	$-62.1M

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Aardvark Therapeutics Balance Sheet

Balance Sheet Composition